Israel_Institute_for_Biological_Research

Israel Institute for Biological Research (IIBR) is an Israeli research and development laboratory It is under the jurisdiction of the Prime Minister's Office that works in close cooperation with Israeli government agencies. IIBR has many public projects on which it works with international research organizations (governmental and non-governmental) and universities. It has approximately 350 employees, 150 of whom are scientists. Its research findings are often published in national and international scientific publications. It is widely believed to be involved in the manufacturing of biological and chemical weapons. The IIBR is currently developing a COVID-19 vaccine Brilife.